Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of the current research project is to evaluate the usability, satisfaction of the antenatal iCBT program including telephone coaching for antenatal and postnatal depressive symptoms and collect nationally representative data on population-based screening of antenatal depressive and anxiety symptoms. The overarching hypothesis is that iCBT, with easy access and affordability, is user friendly and well accepted. In addition to examining the treatment response by questionnaires, we will study the infant development comprehensively as well as potential physiological changes associated with antenatal depression or its treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CBT Intervention | Experimental | Digitalized CBT intervention with phone coaching Arm Description: Participants receive weekly sessions of internet-based CBT, including telephone coaching |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Digitalized CBT with phone coaching | Behavioral | Digitally delivered CBT intervention with weekly phone coaching |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in the Edinburgh Postnatal Depression Scale (EPDS) | EPDS is a ten-item self-report questionnaire originally developed to screen for postpartum depression. The respondents are asked about the symptoms of depression. The total score ranges from 0 to 30. | Baseline and 11 weeks after baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Change in the General Anxiety Disorder 7-item scale (GAD-7) | To assess the change in anxiety symptoms from baseline to follow-up, we will use the Generalized Anxiety Disorder 7-item Scale (GAD-7) (Spitzer, Kroenke, Williams, & Löwe, 2006), which is a brief screening measure including seven items asking about anxiety symptoms experienced in the previous two weeks. | Baseline and 11 weeks after baseline |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Andre Sourander, Professor | Uiniversity of Turku | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Turku | Turku | Finland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003863 | Depression |
| D003865 | Depressive Disorder, Major |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D003866 | Depressive Disorder |
| D019964 | Mood Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Change in the Beck Depression Inventory II (BDI-II) | To assess the change in depressive symptoms BDI-II will be used. | Baseline and 11 weeks after baseline |
| Social Phobia Inventory (SPIN) | To assess the change in Social Phobia SPIN will be used | Baseline and 11 weeks after baseline |
| Pregnancy-Related Anxiety Questionnaire-Revised (PRAQ) | To assess the change in pregnancy related anxiety PRAQ will be used | Baseline and 11 weeks after baseline |
| Perceived Stress Scale (PSS) | To assess the change in perceived stress PSS will be used | Baseline and 11 weeks after baseline |
| D001523 |
| Mental Disorders |